cisplatin,pembrolizumab,gemcitabine,pemetrexed
merck
['keytruda', 'nsclc', 'sclc', '$mrk']
$mrk asco 2023: keytruda becomes a new option in perioperative nsclc via 
News and analysis of biomedical, biopharma, biotech, biosciences, pharmaceutical, and technology equities